Presentation ESC 2013

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Presenter: 32040|Roxana Mehran

September 01, 2013

REGISTER for free or LOG IN to view this content

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Prevention

CAD Pharma

Clinical Pharma

Presentation

ESC 2013

Up Next

Presentation TCT 2013

Use Of Troponin To Diagnose Peri-procedural Myocardial Infarction: Effect On Composite Endpoints In The British Bifurcation Coronary Study (BBC ONE)

Presenter: JAMES COCKBURN

January 31, 2013

More slides +

Presentation TCT 2013

A Preliminary Study of Biodegradable Iron Stent in Mini-Swine Coronary Artery

Presenter: Chao Wu

January 31, 2013

Presentation TCT 2013

The Risk of In-Hospital Bleeding and Long-Term Mortality in Patients with ST Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

Presenter: H. Boden

January 31, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.